A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease
Clinical trial NCT04583735 · COMPLETED
Trial details
- NCT number
- NCT04583735
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-02
- Primary completion
- 2023-03-17
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.